Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Monocytic Leukemia · Newly Diagnosed

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Sheng-Li Xue, M.D.) · slxue@suda.edu.cn · +86 512 6778 1139

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML

Acute Monocytic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Miami, United States · Portland, United States

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

Leukemia · Myeloid Leukemia · Monocytic Leukemia

Abroad (travel likely)RecruitingPHASE1

Aurora, United States

Venetoclax Combined With CACAG Regimen Versus "3+7" Regimen in the Treatment of Acute Monocytic Leukemia

Acute Monocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Beijing, China

Halt Aging in Survivors of Blood Cancers

Hematological Malignancy · Leukemia · Lymphoid Leukemia

Abroad (travel likely)Recruiting

Omaha, United States